Gibriel Abdullah A, Abou-Elew Maha H, Masmoudi Saber
Biochemistry and Molecular Biology Department, Faculty of Pharmacy, The British University in Egypt (BUE), P.O. Box 259, 11728, Cairo, Egypt.
Otorhinolaryngology Department, Audio-Vestibular Unit, Faculty of Medicine, Kasr Al-Aini El-Manial University Hospital, Cairo University, Giza, Egypt.
Mol Biol Rep. 2019 Apr;46(2):2139-2145. doi: 10.1007/s11033-019-04667-0. Epub 2019 Feb 7.
Hearing loss (HL) is a global sensory disorder that affects children and deprives them from their rights to enjoy standard social and educational levels. Although hundreds of genetic mutations across several genes have been linked to HL, very limited studies are available on Egyptian population which has high rate of consanguinity and HL. The frequency of the p.Gly12Valfs2, p.Trp24 and p.Trp77Arg mutations in GJB2 along with the p.Arg81Gln variant in LRTOMT gene was investigated in Egyptian patients. 103 non-syndromic HL (NSHL) Egyptian patients and 100 control subjects were recruited in this study. PCR-RFLP and Direct sequencing were performed to screen and confirm presence/absence of those mutations in Egyptian population. The p.Gly12Valfs2 mutation was found in eight patients (7.8%) (six homozygous and two heterozygous) with an allele frequency of 6.8%. The p.Trp24 and p.Trp77Arg were absent in both HL patients and controls. Another one patient had the heterozygous variant for p.Arg81Gln in LRTOMT gene. This study reports, for the first time, the presence of a heterozygous change for the p.Arg81Gln in LRTOMT gene in one Egyptian patient. The p.Gly12Valfs2 mutation, but not the p.Trp24 nor the p.Trp77Arg, in GJB2 is the most frequent variant among Egyptian patients and would therefore be recommended for genetic counseling and diagnosis.
听力损失(HL)是一种全球性的感觉障碍,影响儿童,剥夺他们享受标准社会和教育水平的权利。尽管多个基因中的数百种基因突变与HL有关,但对于近亲结婚率和HL发病率都很高的埃及人群,相关研究非常有限。本研究调查了埃及患者中GJB2基因的p.Gly12Valfs2、p.Trp24和p.Trp77Arg突变频率以及LRTOMT基因中的p.Arg81Gln变体。本研究招募了103名非综合征性HL(NSHL)埃及患者和100名对照受试者。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)和直接测序法筛查并确认这些突变在埃及人群中的存在与否。在8例患者(7.8%)中发现了p.Gly12Valfs2突变(6例纯合子和2例杂合子),等位基因频率为6.8%。HL患者和对照中均未发现p.Trp24和p.Trp77Arg突变。另一名患者在LRTOMT基因中有p.Arg81Gln的杂合变体。本研究首次报道了一名埃及患者LRTOMT基因中存在p.Arg81Gln杂合变化。GJB2基因中的p.Gly12Valfs2突变,而非p.Trp24或p.Trp77Arg突变,是埃及患者中最常见的变体,因此建议用于遗传咨询和诊断。